{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:39:27Z","timestamp":1780915167695,"version":"3.54.1"},"reference-count":29,"publisher":"American Academy of Pediatrics (AAP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND:<\/jats:title>\n                  <jats:p>Infants born prematurely or with underlying conditions are at increased risk of severe rotavirus disease and associated complications. Given the theoretical risk of nosocomial transmission of vaccine-type rotavirus, rotavirus vaccination is recommended for infants at or after discharge from neonatal care settings. Because the first dose should be administered by 104 days of age, some infants may be age-ineligible for vaccination if delayed until discharge.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>This prospective cohort included infants admitted to an urban academic medical center between birth and 104 days who received care in intensive care settings. Pentavalent human-bovine reassortant rotavirus vaccine (RV5) was used, per routine clinical care. Stool specimens were collected weekly (February 2013\u2013April 2014) and analyzed for rotavirus strains using real-time reverse transcription\u2013polymerase chain reaction. Demographic and vaccine data were collected. RV5 safety was not assessed.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>Of 385 study infants, 127 were age-eligible for routine vaccinations during hospitalization. At discharge, 32.7% were up-to-date for rotavirus vaccination, compared with 82.7% for other vaccinations. Of rotavirus-unvaccinated infants, 42.6% were discharged at age &amp;gt;104 days and thus vaccination-ineligible. Of 1192 stool specimens collected, rotavirus was detected in 13 (1.1%): 1 wild-type strain from an unvaccinated infant; 12 vaccine-type strains from 9 RV5-vaccinated infants. No vaccine-type rotavirus cases were observed among unvaccinated infants (incidence rate: 0.0 [95% confidence interval: 0.0\u20131.5] cases per 1000 patient days at risk).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>These data suggest that delaying rotavirus vaccination until discharge from the hospital could lead to missed vaccination opportunities and may be unnecessary in institutions using RV5 with comparable infection control standards.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/peds.2017-1110","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T08:15:13Z","timestamp":1512548113000},"source":"Crossref","is-referenced-by-count":27,"title":["Risk of Rotavirus Nosocomial Spread After Inpatient Pentavalent Rotavirus Vaccination"],"prefix":"10.1542","volume":"141","author":[{"given":"Annika M.","family":"Hofstetter","sequence":"first","affiliation":[{"name":"Department of Pediatrics, University of Washington, Seattle, Washington;"},{"name":"Seattle Children\u2019s Research Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Lacombe","sequence":"additional","affiliation":[{"name":"Seattle Children\u2019s Research Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eileen J.","family":"Klein","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Washington, Seattle, Washington;"},{"name":"Seattle Children\u2019s Research Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charla","family":"Jones","sequence":"additional","affiliation":[{"name":"Seattle Children\u2019s Research Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Strelitz","sequence":"additional","affiliation":[{"name":"Seattle Children\u2019s Research Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Jacobson","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Washington, Seattle, Washington;"},{"name":"Seattle Children\u2019s Research Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daksha","family":"Ranade","sequence":"additional","affiliation":[{"name":"Seattle Children\u2019s Research Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Leanne","family":"Ward","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slavica","family":"Mijatovic-Rustempasic","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Evans","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Wikswo","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Bowen","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umesh D.","family":"Parashar","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C.","family":"Payne","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet A.","family":"Englund","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, University of Washington, Seattle, Washington;"},{"name":"Seattle Children\u2019s Research Institute, Seattle, Washington; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2018,1,1]]},"reference":[{"issue":"12","key":"2021120916300385000_B1","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1097\/01.inf.0000243777.01375.5b","article-title":"A case-control study to determine risk factors for hospitalization for rotavirus gastroenteritis in U.S. children.","volume":"25","author":"Dennehy","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"2021120916300385000_B2","doi-asserted-by":"crossref","DOI":"10.1542\/peds.103.1.e3","article-title":"Perinatal risk factors for infant hospitalization with viral gastroenteritis.","volume":"103","author":"Newman","year":"1999","journal-title":"Pediatrics"},{"issue":"1","key":"2021120916300385000_B3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0022-3476(80)80131-4","article-title":"Chronic rotavirus infection in immunodeficiency.","volume":"97","author":"Saulsbury","year":"1980","journal-title":"J Pediatr"},{"issue":"12","key":"2021120916300385000_B4","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1097\/INF.0b013e31814521cb","article-title":"Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants.","volume":"26","author":"Goveia","year":"2007","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"2021120916300385000_B5","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2013-3504","article-title":"Safety of rotavirus vaccine in the NICU.","volume":"133","author":"Monk","year":"2014","journal-title":"Pediatrics"},{"issue":"45","key":"2021120916300385000_B6","doi-asserted-by":"crossref","first-page":"8141","DOI":"10.1016\/j.vaccine.2011.08.028","article-title":"Rotavirus shedding in premature infants following first immunization.","volume":"29","author":"Smith","year":"2011","journal-title":"Vaccine"},{"issue":"39","key":"2021120916300385000_B7","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1016\/j.vaccine.2015.08.015","article-title":"Evaluation of pentavalent rotavirus vaccination in neonatal intensive care units.","volume":"33","author":"Thrall","year":"2015","journal-title":"Vaccine"},{"issue":"1","key":"2021120916300385000_B8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/jpids\/pit060","article-title":"The safety and immunogenicity of rotavirus vaccination in infants with intestinal failure.","volume":"3","author":"Javid","year":"2014","journal-title":"J Pediatric Infect Dis Soc"},{"key":"2021120916300385000_B9","first-page":"1","article-title":"Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP) [published correction appears in MMWR Recomm Rep. 2010;59(33):1074].","volume":"58","author":"Cortese","year":"2009","journal-title":"MMWR Recomm Rep"},{"issue":"22","key":"2021120916300385000_B10","first-page":"687","article-title":"Addition of severe combined immunodeficiency as a contraindication for administration of rotavirus vaccine.","volume":"59","author":"Centers for Disease Control and Prevention (CDC)","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"41","key":"2021120916300385000_B11","first-page":"1427","article-title":"Addition of history of intussusception as a contraindication for rotavirus vaccination.","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"2021120916300385000_B12","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2013-0291","article-title":"Rotavirus vaccination of very low birth weight infants at discharge from the NICU.","volume":"132","author":"Stumpf","year":"2013","journal-title":"Pediatrics"},{"issue":"5","key":"2021120916300385000_B13","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/infdis\/jiw233","article-title":"Rotavirus strain trends during the postlicensure vaccine era: United States, 2008-2013.","volume":"214","author":"Bowen","year":"2016","journal-title":"J Infect Dis"},{"issue":"1","key":"2021120916300385000_B14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/cid\/cit164","article-title":"Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children &lt;5 years of age, 2009-2011.","volume":"57","author":"Payne","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"3","key":"2021120916300385000_B15","doi-asserted-by":"crossref","first-page":"767","DOI":"10.4161\/hv.27388","article-title":"Real-time RT-PCR assays to differentiate wild-type group A rotavirus strains from Rotarix(\u00ae) and RotaTeq(\u00ae) vaccine strains in stool samples.","volume":"10","author":"Gautam","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"2021120916300385000_B16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jviromet.2015.07.012","article-title":"Multiplexed one-step RT-PCR VP7 and VP4 genotyping assays for rotaviruses using updated primers.","volume":"223","author":"Esona","year":"2015","journal-title":"J Virol Methods"},{"issue":"9","key":"2021120916300385000_B17","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1128\/JCM.01192-13","article-title":"Sensitive and specific quantitative detection of rotavirus A by one-step real-time reverse transcription-PCR assay without antecedent double-stranded-RNA denaturation.","volume":"51","author":"Mijatovic-Rustempasic","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"8","key":"2021120916300385000_B18","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.2105\/AJPH.2004.046284","article-title":"Timeliness of childhood immunizations: a state-specific analysis.","volume":"95","author":"Luman","year":"2005","journal-title":"Am J Public Health"},{"issue":"5","key":"2021120916300385000_B19","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/jp.2011.111","article-title":"Underimmunization at discharge from the neonatal intensive care unit.","volume":"32","author":"Navar-Boggan","year":"2012","journal-title":"J Perinatol"},{"key":"2021120916300385000_B20","unstructured":"US Department of Health and Human Services\n          . Healthy people 2020: immunization and infectious diseases. Available at: www.healthypeople.gov\/2020\/topics-objectives\/topic\/immunization-and-infectious-diseases\/objectives. Accessed September 5, 2017"},{"issue":"17","key":"2021120916300385000_B21","first-page":"521","article-title":"Rotavirus vaccination coverage among infants aged 5 months - immunization information system sentinel sites, United States, June 2006-June 2009.","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"33","key":"2021120916300385000_B22","doi-asserted-by":"crossref","first-page":"889","DOI":"10.15585\/mmwr.mm6433a1","article-title":"National, state, and selected local area vaccination coverage among children aged 19-35 months - United States, 2014.","volume":"64","author":"Hill","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"2021120916300385000_B23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Engl J Med"},{"key":"2021120916300385000_B24","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/S1201-9712(07)60020-4","article-title":"The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine.","volume":"11","author":"Dennehy","year":"2007","journal-title":"Int J Infect Dis"},{"issue":"24","key":"2021120916300385000_B25","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1016\/j.vaccine.2011.03.074","article-title":"Detection of fecal shedding of rotavirus vaccine in infants following their first dose of pentavalent rotavirus vaccine.","volume":"29","author":"Yen","year":"2011","journal-title":"Vaccine"},{"issue":"10","key":"2021120916300385000_B26","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.vaccine.2013.08.041","article-title":"Comparison of virus shedding after lived attenuated and pentavalent reassortant rotavirus vaccine.","volume":"32","author":"Hsieh","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"2021120916300385000_B27","doi-asserted-by":"crossref","first-page":"E221","DOI":"10.1111\/jpc.12113","article-title":"Prevalence of viruses in stool of premature neonates at a neonatal intensive care unit.","volume":"49","author":"Naing","year":"2013","journal-title":"J Paediatr Child Health"},{"issue":"5","key":"2021120916300385000_B28","first-page":"49","article-title":"Rotavirus vaccines. WHO position paper \u2013 January 2013.","volume":"88","author":"World Health Organization","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"key":"2021120916300385000_B29","doi-asserted-by":"publisher","DOI":"10.1093\/jpids\/pix057","article-title":"National estimates of reductions in acute gastroenteritis-related hospitalizations and associated costs in US children following implementation of rotavirus vaccines [published online ahead of print August 10, 2017]","author":"Leshem","journal-title":"J Pediatric Infect Dis Soc"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2017-1110\/1065701\/peds_20171110.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2017-1110\/1065701\/peds_20171110.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T04:44:14Z","timestamp":1639111454000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/141\/1\/e20171110\/37689\/Risk-of-Rotavirus-Nosocomial-Spread-After"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,1,1]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2017-1110","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,1]]},"article-number":"e20171110"}}